AKEBIA THERAPEUTICS, INC. Increase (Decrease) in Deferred Revenue
AKEBIA THERAPEUTICS, INC. (AKBA) reported Increase (Decrease) in Deferred Revenue of -$28.10 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-11-08
- AKEBIA THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was -$7.98M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$10.73M, a 117.46% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$9.39M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$22.86M, a 114.54% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$14.42M, a 107.31% decline from fiscal 2016.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2016 was $197.29M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$7.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$18.71M derived: sum of 2 quarters · filed 2018-11-08 | -$28.10M 10-Q · filed 2018-11-08 | -$50.97M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | -$10.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$20.12M 10-Q · filed 2018-08-08 | -$42.99M derived: sum of 3 quarters · filed 2018-08-08 | -$75.13M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-03-31 | -$9.39M 10-Q · filed 2018-05-09 | -$32.26M derived: sum of 2 quarters · filed 2018-05-09 | -$64.40M derived: sum of 3 quarters · filed 2018-11-08 | -$2.95M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-12-31 | -$22.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$55.01M derived: sum of 2 quarters · filed 2018-11-08 | $6.44M derived: sum of 3 quarters · filed 2018-11-08 | -$14.42M 10-K · filed 2018-03-12 |
| 2017-09-30 | -$32.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $29.31M derived: sum of 2 quarters · filed 2018-11-08 | $8.44M 10-Q · filed 2018-11-08 | $165.73M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $61.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $40.59M 10-Q · filed 2018-08-08 | $197.88M derived: sum of 3 quarters · filed 2018-08-08 | $197.88M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | -$20.87M 10-Q · filed 2018-05-09 | $136.42M derived: sum of 2 quarters · filed 2018-05-09 | $136.42M derived: sum of 3 quarters · filed 2018-05-09 | $136.42M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $157.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $157.29M derived: sum of 2 quarters · filed 2018-03-12 | $157.29M derived: sum of 3 quarters · filed 2018-03-12 | $197.29M 10-K · filed 2018-03-12 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $40.00M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $40.00M 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $40.00M 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |